The Bright Side of AI #10: Tailoring Getty Images, Decoding Parkinson's in Minutes, and AI's Take on Female Hormones
AI continues to make our lives better in more ways than one — not just by promoting greener solutions or simplifying everyday tasks. It's increasingly making strides in the healthcare sector too. Ready to dive into the latest AI breakthroughs? Welcome to the 10th installment of "The Bright Side of AI!"
If you regularly use royalty-free images for your projects or website, chances are you're familiar with Getty Images, a big player in the industry. The downside of using these images? Well, everyone else is using them too, which may not set your project apart from the rest. So what are your options? You could create your own images, but that's time-consuming and costly. Now there's a better way: "Generative AI by Getty Images".
Getty Images has rolled out its own AI-powered generative art tool, backed by Nvidia technology. This tool can generate images based on the text you input. What's more, Getty offers its standard royalty-free license for images created through this tool, complete with protection against copyright infringement lawsuits.
Another perk? The generated content won't be added to Getty's general library for others to license. Plus, if these images are used to retrain the AI model, the original contributors get compensated. It's an innovative approach that could pave the way for better legal frameworks in the industry.
Parkinson's disease impacts over 10 million people globally, and the numbers keep rising. Despite being discovered more than 200 years ago, progress in combating the disease has been slow—until AI entered the picture. The Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to fast-track Parkinson's diagnosis using AI. The technology processes brain images to identify the presence of the Parkinson's gene.
The initial results are promising: the AI boasts a 92% accuracy rate and completes the analysis in mere minutes, compared to the average five hours it usually takes. Future steps include fine-tuning the process to differentiate stages of the disease and expanding its application to living patients.
AI is not just aiding Parkinson's research; it's also making headway in diagnosing Polycystic Ovary Syndrome (PCOS), a prevalent hormonal disorder in women that can lead to diabetes, excess hair growth, and fertility issues. After sifting through years of data, AI shows an 80-90% accuracy rate in detecting PCOS. While not as high as for Parkinson's, the figure is impressive given the diagnostic challenges of PCOS, which often overlaps with symptoms of other conditions like type 2 diabetes and sleep disorders.
The HUMAN Protocol Foundation makes no representation, warranty, or undertaking, express or implied, as to the accuracy, reliability, completeness, or reasonableness of the information contained here. Any assumptions, opinions, and estimations expressed constitute the HUMAN Protocol Foundation’s judgment as of the time of publishing and are subject to change without notice. Any projection contained within the information presented here is based on a number of assumptions, and there can be no guarantee that any projected outcomes will be achieved.